Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Echium amoenum extract is a botanical product derived from the dried flowers of *Echium amoenum*, a medicinal plant native to Iran. The extract contains active phenolic compounds, including rosmarinic acid and anthocyanins such as cyanidin-3-glucoside and delphinidin. It exerts therapeutic effects through multiple mechanisms, including antioxidant activity, inhibition of acetylcholinesterase, and anti-inflammatory actions via the suppression of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and pro-inflammatory cytokines. Clinical research has investigated its efficacy in treating obsessive-compulsive disorder (OCD), generalized anxiety disorder (GAD), and mild to moderate depression, while preclinical models suggest potential benefits in Alzheimer's disease and pain management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on echium amoenum extract.